Redmile Group’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-82,098
| Closed | -$3.3M | – | 52 |
|
|
2025
Q1 | $3.3M | Sell |
82,098
-10,500
| -11% | -$422K | 0.31% | 43 |
|
|
2024
Q4 | $4.36M | Sell |
92,598
-4,518
| -5% | -$213K | 0.3% | 46 |
|
|
2024
Q3 | $5.13M | Sell |
97,116
-14,751
| -13% | -$779K | 0.3% | 46 |
|
|
2024
Q2 | $6.06M | Sell |
111,867
-49,733
| -31% | -$2.69M | 0.37% | 46 |
|
|
2024
Q1 | $11.3M | Buy |
+161,600
| New | +$11.3M | 0.42% | 53 |
|